Precision Medicine A New Era Hazem Assi American University of Beirut

Slides:



Advertisements
Similar presentations
Cap.org v. # Pathologists’ Role in Coordinated Care and Managing Patient Populations.
Advertisements

Statistical Issues in Incorporating and Testing Biomarkers in Phase III Clinical Trials FDA/Industry Workshop; September 29, 2006 Daniel Sargent, PhD Sumithra.
Importance of Pharmacogenetics in Oncology Richard Pazdur, MD. Director Office of Oncology Drug Products Center for Drug Evaluation and Research Food and.
Clinical Perspective. Screening/Prevention Who is at risk for what type Decision to Intervene: Risk Assessment normal Evidence of Disease Disability Death.
Cancer Clinical Trials A treatment option for cancer patients.
Re-Examination of the Design of Early Clinical Trials for Molecularly Targeted Drugs Richard Simon, D.Sc. National Cancer Institute linus.nci.nih.gov/brb.
CR-1 Concluding Remarks and Risk/Benefit Summary Mace L. Rothenberg, MD Professor of Medicine Vanderbilt Ingram Cancer Center.
Primary Health care European Project on Alkohol Michael N. Smolka Central Institute of Mental Health Department of Addiction Medicine Mannheim, Germany.
The Role of Personalized Medicine in our Future Delivery System Moderator: Edward Abrahams, Ph.D., President, Personalized Medicine Coalition Panelists:
The Research and Development Goals of the Global Plan to Stop TB Marcos Espinal Executive Secretary.
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
April 2005 How Patients Can Benefit From Molecular Imaging Paula M. Jacobs, Ph.D Vice President Advanced Magnetics, Inc.
Developing medicines for the future and why it is challenging Angela Milne.
NICE - in evidence based commissioning Gateshead Council Gillian Mathews, Implementation Consultant - North 9 September 2011.
Mammography Advantage Pathway Using the MAP: Mammography Advantage Pathway Resource Kit©
 SC Guidelines for Diabetes Care Screening for Diagnosis of Diabetes To test for diabetes or to assess risk of future diabetes, either A1C, Fasting.
Is the conscientious explicit and judicious use of current best evidence in making decision about the care of the individual patient (Dr. David Sackett)
Copyleft Clinical Trial Results. You Must Redistribute Slides The American College of Cardiology Foundation / American Heart Association Clopidogrel Recommendations.
SEEK is a drug-discovery group that uses a pioneering scientific and commercially-driven approach to create breakthrough medicines which address major.
MedBiquitous May 15, 2008 Integrating Quality Improvement Data into a Web- based CME Activity MedBiquitous May 15, 2008 Annette D. Boyer, R.Ph. CECity.com,
Understanding Community Cancer Care Importance of the Care & Advocating for the Care Presented By: Dr. Jeffrey L. Vacirca, M.D.,FACP CEO, NSHOA Cancer.
Jan 2002 EDMA The central role of the Medical Laboratory in a World of Managed Health An EDMA presentation of the benefits of in vitro testing as a basis.
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Fuel Cell Market size worth $25.5bn by 2024Low Power Wide Area Network.
Rheumatology Mastery in Ankylosing Spondylitis
Antimicrobial Stewardship
Medication therapy management
NCT: Gaining Medical Insights and Enhancing Care for Cancer Patients with SAP HANA® Organization National Center for Tumor Diseases (NCT) Heidelberg, part.
Integrating Genetics & Genomics Education into Nursing Workforce
Data-Drive Analytics for Precision Medicine
Clinical practice guidelines and Clinical audit
Because we would like to optimally individualize patient care, n-of-1 randomized clinical trials are at the top of the hierarchy of study designs, followed.
Accelerating Precision Medicine for Advanced Cancer Patients
Clinical use of PAH drugs based on functional class
P. Therasse, S. Carbonnelle, J. Bogaerts 
Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.
2017 Patient Navigation Best Practices
Integrating Genetics & Genomics Education into Nursing Workforce
“Next Generation of Connected Health”
Clinical Trials in IBD.
Cancer Cachexia in GI Malignancies
Update of breast cancer
Advanced NSCLC Without Actionable Mutations
Positive Impacts of Developing Novel Endpoints Generated by Mobile Technology for Use in Clinical Trials* SPECIFIC BENEFITS   SHORT-TERM MEDIUM-TERM LONG-TERM.
Cancer Care Benefit that Uses Evidence-Based Guidelines to Assure Most Efficient Use of Benefit Plan Dollars HR Specialty Products & Services Catalogue.
Figure 2 Multiscale modelling in oncology
Figure 5 Schematic illustration of different clinical trial designs
Oncology Care Model 2.0 The Universal Payment Model in Oncology
Optimizing Patient Outcomes in IBD
New Pathways in Lipid Care
Evidence-based Medicine Curriculum
Future Health Outlook April 23, 2018.
EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.
Medicines Management – Intelligent Target Dem 3 Mini Collaborative
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Optimizing Insulin Therapy in Primary Care: Basal Plus Incretin Combinations.
Why study Brain tumour Biology???
Fig. 1. scRNA-seq applications in cancer medicine.
Types of biomarkers/biosignatures to be used for cardiovascular disease. Types of biomarkers/biosignatures to be used for cardiovascular disease. There.
When Good Isn't Good Enough
On the Design of Combination Cancer Therapy
Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.
Session 3: Coverage and Reimbursement for Genetic Testing
Uptitration of Medications in HF: Start Low but Aim High and Stay High
Saturation analysis and the discovery of actionability of mutational hotspots. Saturation analysis and the discovery of actionability of mutational hotspots.
Single-cell analyses to tailor treatments
Opening remarks Welcome to CUP 2019: Cancer of Unknown Primary in the Era of Precision Medicine Focus: Contemporary Clinical Management and International.
Evidence Based Diagnosis
Possible outcomes of therapeutic treatments using the spiral model.
Uncovering the Right Sequence
Presentation transcript:

Precision Medicine A New Era Hazem Assi American University of Beirut

and help physicians to apply more effective treatments What do we mean? Precision Medicine and Precision Oncology are the terms we use to describe: Advanced diagnostic profiling Therapeutic interventions tailored to suit Outcomes followed up Learnings shared dynamically Precision Medicine Using Advanced Diagnostic Profiling we identify how each patient cancer differs at the molecular level and help physicians to apply more effective treatments 2 2

Evidence Based Medicine Precision Medicine New fast high fidelity learning loops are needed to accelerate access to better care Intervention Outcome Tracking Guidelines Treatment Pathways Advanced Diagnostics Invent Trial Register Reimburse Adopt Guidelines Registries Phase 4 Studies Pharmacovigilance 3 3

Patient Centric Approach Patient A Drug Patient A Patient B Patient C Drug A Drug B Drug C THE FUTURE 4

to insufficient intervention to excessive intervention Investing In Precision Medicine Optimizes Clinical And Financial Outcomes Waste due to insufficient intervention Waste due to excessive intervention Outcome We find the people within a group that are most likely to respond to targeted therapy, thereby eliminating waste from either insufficient or excessive intervention. Insufficient Intervention: Patient receives a false negative result due to less sensitive testing and does not receive the benefit of associated targeted therapy Excessive Intervention: Patient received a targeted agent without a molecular diagnostic testing that would indicate the appropriateness of the therapy Insufficient Intervention Excessive Intervention Optimal Intervention LB/FMI/1710/0007